Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer

PSA-TRICOM (PROSTVAC) is a novel vector-based vaccine designed to generate a robust immune response against prostate-specific antigen (PSA)–expressing tumor cells. The purpose of this report is to present an overview of both published studies and new data in the evaluation of immune responses to the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gulley, James L., Madan, Ravi A., Tsang, Kwong Y., Jochems, Caroline, Marté, Jennifer L., Farsaci, Benedetto, Tucker, Jo A., Hodge, James W., Liewehr, David J., Steinberg, Seth M., Heery, Christopher R., Schlom, Jeffrey
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004961/
https://ncbi.nlm.nih.gov/pubmed/24778277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-13-0108
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares